The Administrative Core will provide an efficient coordination of the component projects and activities, monitor the progress in the research programs, and assist in the development of plans for the future of the Center. It will coordinate, provide logistic support, and maintain budgetary oversight of the overall CCNE organizational framework, including the scientific cores and the education and training program. An internal Executive Committee and an external Advisory Board will provide scientific guidance and administrative oversight of the Center. This Core will handle the administrative details of the Center's affiliations with NCIdesignated Cancer Centers, SPOREs, and other CCNEs. Administrative Core will include the """"""""scientific"""""""" PI (Vladimir Torchilin, Director), """"""""clinical"""""""" PI (Nahum Goldberg), Associate Director (Mansoor Amiji), Center Administrator (Boris Levchenko) and Assistant (Grants and Contracts Specialist;to be named) to provide a day-by-day management of the CCNE and arrange regular meeting of all key participants, exchange of new information and samples between participants. The Administrative Core will function in close connection with the Executive Committee (to be assembled if and when this proposal is funded) and Advisory Board (to be assembled if and when this proposal is funded). This Core will also be facilitating contacts between individual investigators of the CCNE and Core Facilities as well as providing a required assistance for preparing regular reports to the NIH.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Specialized Center--Cooperative Agreements (U54)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-GRB-S (M1))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Northeastern University
United States
Zip Code
Jhaveri, Aditi; Deshpande, Pranali; Pattni, Bhushan et al. (2018) Transferrin-targeted, resveratrol-loaded liposomes for the treatment of glioblastoma. J Control Release 277:89-101
Wang, Tao; Narayanaswamy, Radhika; Ren, Huilan et al. (2018) Phage-derived protein-mediated targeted chemotherapy of pancreatic cancer. J Drug Target 26:505-515
Kumar, Gaurav; Goldberg, S Nahum; Gourevitch, Svetlana et al. (2018) Targeting STAT3 to Suppress Systemic Pro-Oncogenic Effects from Hepatic Radiofrequency Ablation. Radiology 286:524-536
Upponi, Jaydev R; Jerajani, Kaushal; Nagesha, Dattatri K et al. (2018) Polymeric micelles: Theranostic co-delivery system for poorly water-soluble drugs and contrast agents. Biomaterials 170:26-36
Petrenko, Valery A; Gillespie, James W (2017) Paradigm shift in bacteriophage-mediated delivery of anticancer drugs: from targeted 'magic bullets' to self-navigated 'magic missiles'. Expert Opin Drug Deliv 14:373-384
van de Ven, Anne L; Tangutoori, Shifalika; Baldwin, Paige et al. (2017) Nanoformulation of Olaparib Amplifies PARP Inhibition and Sensitizes PTEN/TP53-Deficient Prostate Cancer to Radiation. Mol Cancer Ther 16:1279-1289
Pattni, Bhushan S; Jhaveri, Aditi; Dutta, Ivy et al. (2017) Targeting energy metabolism of cancer cells: Combined administration of NCL-240 and 2-DG. Int J Pharm 532:149-156
Pattni, Bhushan S; Nagelli, Srikar G; Aryasomayajula, Bhawani et al. (2016) Targeting of Micelles and Liposomes Loaded with the Pro-Apoptotic Drug, NCL-240, into NCI/ADR-RES Cells in a 3D Spheroid Model. Pharm Res 33:2540-51
Sriraman, Shravan Kumar; Salzano, Giusseppina; Sarisozen, Can et al. (2016) Anti-cancer activity of doxorubicin-loaded liposomes co-modified with transferrin and folic acid. Eur J Pharm Biopharm 105:40-9
Perche, Federico; Biswas, Swati; Patel, Niravkumar R et al. (2016) Hypoxia-Responsive Copolymer for siRNA Delivery. Methods Mol Biol 1372:139-62

Showing the most recent 10 out of 86 publications